Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Stocks Under $10 to Buy Before They Double

By Josh Enomoto, InvestorPlace Contributor

Generally speaking, investors seeking long-term success should follow the guidance of Warren Buffett rather than target cheap stocks to buy under $10. Fundamentally, the Oracle…

Wave Goodbye: 3 Stocks to Ditch as Revenge Travel Dies Down

By Josh Enomoto, InvestorPlace Contributor

Although the collective pent-up demand for social experiences amid the worst of the Covid-19 crisis led to the revenge travel phenomenon, this catalyst may be…

The Top 7 Defense Stocks for an Unsteady World

By Josh Enomoto, InvestorPlace Contributor

Given the sensitive nature of current and ongoing geopolitical flashpoints, the concept of top defense stocks to buy seems controversial. Indeed, the sector has always…

CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy

By Josh Enomoto, InvestorPlace Contributor

Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.

Michael Burry Reigns Victorious Amid Market Correction

By Josh Enomoto, InvestorPlace Contributor

With the market correction confirming the original bearish thesis of Michael Burry, the contrarian should take a victory lap.

3 Dividend Kings to Buy for Safe Dividend Growth: October 2023

By Josh Enomoto, InvestorPlace Contributor

With the market just demonstrating the possibility of a downcycle in the future, investors may want to target dividend stocks. Fundamentally, the case for passive…

7 Undervalued Stocks That Analysts Love Right Now

By Josh Enomoto, InvestorPlace Contributor

Ahead of possible volatility in the market, investors may find some measure of confidence in undervalued stocks. From a psychological perspective, companies that sit well…

Why Is PaxMedica (PXMD) Stock Up Today?

By Josh Enomoto, InvestorPlace Contributor

PaxMedica recently demonstrated encouraging progress with a key therapeutic, but PXMD stock remains highly speculative.

7 of the Best Cheap Stocks to Buy Under $5 in October 2023

By Josh Enomoto, InvestorPlace Contributor

Generally speaking, you get what you pay for, which should be a warning for speculating on low-priced securities, even if they’re labeled the best cheap…

3 Cheap Stocks to Buy Under $1 in October 2023

By Josh Enomoto, InvestorPlace Contributor

For the extreme gambler who has done homework regarding risk and rewards, few thrills excite as much as cheap stocks to buy under $1. By…

Load More